Evidence map›Paper›PMID 33398329›Full record

ArticleNucleic acids research2021

mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1.

Jian-Jun Jia, Roni M Lahr, Michael T Solgaard, Bruno J Moraes, Roberta Pointet, An-Dao Yang, Giovanna Celucci, Tyson E Graber, Huy-Dung Hoang, Marius R Niklaus and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RiboScreenBiomedicines · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The role ofFrontiers in endocrinology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 6 countries.

Jian-Jun JiaChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Roni M LahrDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Michael T SolgaardDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Bruno J MoraesGABBA PhD Program, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.
Roberta PointetChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
An-Dao YangChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Giovanna CelucciChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Tyson E GraberChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Huy-Dung HoangChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Marius R NiklausChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Izabella A PenaChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Anne K HollensenDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Ewan M SmithCancer Research UK Beatson Institute, Glasgow, UK.
Malik Chaker-MargotBiozentrum, University of Basel, Basel, Switzerland.
Leonie AntonBiozentrum, University of Basel, Basel, Switzerland.
Christopher DajadianDepartment of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montréal, Canada.
Mark LivingstoneDepartment of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montréal, Canada.
Jaclyn HearndenDepartment of Biochemistry, Rosalind and Morris Goodman Cancer Centre, McGill University, Montréal, Canada.
Xu-Dong WangDepartment of Biochemistry, UT Southwestern Medical Center, Dallas, TX, USA.
Yonghao YuDepartment of Biochemistry, UT Southwestern Medical Center, Dallas, TX, USA.
Timm MaierBiozentrum, University of Basel, Basel, Switzerland.
Christian K DamgaardDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Andrea J BermanDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Tommy AlainChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
Bruno D FonsecaChildren's Hospital of Eastern Ontario (CHEO) Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
University of Ottawa · CAAarhus University · DKMcGill University Health Centre · CAUniversity of Basel · CHSouthwestern Medical Center · USUniversity of Pittsburgh · USCancer Research UK Scotland Institute · GBUniversidade do Porto · PT

Funding

Mechanisms of mRNA regulation by La-related protein 1R01GM116889 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BERMAN, ANDREA J. · 2016 to 2021
$1.6M
NIGMS NIH HHS R01 GM116889
6 · The paper itself

Abstract

LARP1 is a key repressor of TOP mRNA translation. It binds the m7Gppp cap moiety and the adjacent 5'TOP motif of TOP mRNAs, thus impeding the assembly of the eIF4F complex on these transcripts. mTORC1 controls TOP mRNA translation via LARP1, but the details of the mechanism are unclear. Herein we elucidate the mechanism by which mTORC1 controls LARP1's translation repression activity. We demonstrate that mTORC1 phosphorylates LARP1 in vitro and in vivo, activities that are efficiently inhibited by rapamycin and torin1. We uncover 26 rapamycin-sensitive phospho-serine and -threonine residues on LARP1 that are distributed in 7 clusters. Our data show that phosphorylation of a cluster of residues located proximally to the m7Gppp cap-binding DM15 region is particularly sensitive to rapamycin and regulates both the RNA-binding and the translation inhibitory activities of LARP1. Our results unravel a new model of translation control in which the La module (LaMod) and DM15 region of LARP1, both of which can directly interact with TOP mRNA, are differentially regulated: the LaMod remains constitutively bound to PABP (irrespective of the activation status of mTORC1), while the C-terminal DM15 'pendular hook' engages the TOP mRNA 5'-end to repress translation, but only in conditions of mTORC1 inhibition.

Indexed as

Protein BiosynthesisAmino Acid MotifsAutoantigensHEK293 CellsHumansMechanistic Target of Rapamycin Complex 1NaphthyridinesPhosphorylationProtein BindingRibonucleoproteinsSerineSirolimusSS-B AntigenThreonineTyrosine1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-oneAutoantigensMechanistic Target of Rapamycin Complex 1NaphthyridinesRibonucleoproteinsSerineSirolimusSS-B AntigenThreonineTyrosine

Identifiers

PMID33398329
PMCPMC8034618
OpenAlexW3118809061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.